NO20064983L - Enterisk opploselig belegg til oralt inntakbare substrater - Google Patents
Enterisk opploselig belegg til oralt inntakbare substraterInfo
- Publication number
- NO20064983L NO20064983L NO20064983A NO20064983A NO20064983L NO 20064983 L NO20064983 L NO 20064983L NO 20064983 A NO20064983 A NO 20064983A NO 20064983 A NO20064983 A NO 20064983A NO 20064983 L NO20064983 L NO 20064983L
- Authority
- NO
- Norway
- Prior art keywords
- orally ingestible
- soluble coating
- ingestible substrates
- enteric soluble
- substrates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
Det beskrives enteriske filmbelegningssystemer for oralt inntakbare substrater som farmasøytiske tabletter og diettsupplementer. I foretrukne aspekter inkluderer de enteriske filmbelegg en etylcellulosedispersjon og en i det vesentlige gastro-uoppløselig poredanner som natriumalginat.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55793404P | 2004-03-31 | 2004-03-31 | |
PCT/US2005/009713 WO2005097082A1 (en) | 2004-03-31 | 2005-03-24 | Enteric coatings for orally ingestible substrates |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20064983L true NO20064983L (no) | 2006-12-19 |
Family
ID=35124814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20064983A NO20064983L (no) | 2004-03-31 | 2006-10-31 | Enterisk opploselig belegg til oralt inntakbare substrater |
Country Status (13)
Country | Link |
---|---|
US (1) | US7709025B2 (no) |
EP (1) | EP1729742A1 (no) |
JP (1) | JP2007530683A (no) |
KR (1) | KR20070007868A (no) |
CN (1) | CN1938006B (no) |
AU (1) | AU2005231145B8 (no) |
BR (1) | BRPI0508075A (no) |
CA (1) | CA2555114C (no) |
IL (1) | IL177225A0 (no) |
MX (1) | MXPA06010488A (no) |
NO (1) | NO20064983L (no) |
WO (1) | WO2005097082A1 (no) |
ZA (1) | ZA200606744B (no) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1663197T1 (sl) | 2003-09-09 | 2008-06-30 | Biogen Idec Internat Gmbh | Uporaba derivatov fumarne kisline za zdravljenje sräśne insuficience in astme |
PT2801355E (pt) | 2004-10-08 | 2015-09-18 | Forward Pharma As | Composições farmacêuticas de libertação controlada compreendendo um éster de ácido fumárico |
JP5649784B2 (ja) * | 2006-02-07 | 2015-01-07 | エフ エム シー コーポレーションFmc Corporation | 組成物、基材を組成物でコーティングする方法、被覆基材、製品、フィルム、ペレット、タブレット及びカプセル |
US8968799B2 (en) * | 2006-09-01 | 2015-03-03 | Rise-N-Shine L.L.C. | Time delayed release mechanism for energizing composition and method of use |
ES2599227T3 (es) * | 2007-02-08 | 2017-01-31 | Biogen Ma Inc. | Neuroprotección en enfermedades desmielinizantes |
DE102007039772A1 (de) | 2007-08-22 | 2009-02-26 | Cavis Microcaps Gmbh | Mikrokapsel und Verfahren zu deren Herstellung |
US20090136650A1 (en) * | 2007-09-18 | 2009-05-28 | Viva Pharmaceuticals Inc. | Enteric coatings for orally ingestible compositions |
US20090074944A1 (en) * | 2007-09-18 | 2009-03-19 | Viva Pharmaceuticals Inc. | Enteric coatings for orally ingestible compositions |
EP2564839B1 (en) | 2009-01-09 | 2016-05-11 | Forward Pharma A/S | Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
US9278070B2 (en) | 2009-05-18 | 2016-03-08 | Sigmoid Pharma Limited | Composition comprising oil drops |
KR101873075B1 (ko) | 2010-08-18 | 2018-06-29 | 에보니크 룀 게엠베하 | 하나 이상의 알긴산 염을 포함하는 위 내성 제약 또는 건강기능식품 제제 |
WO2012059937A1 (en) * | 2010-11-01 | 2012-05-10 | Abbott Healthcare Private Limited | Modifies release pharmaceutical compositons for nsaids |
GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
US20150086628A1 (en) * | 2012-05-03 | 2015-03-26 | Cipla Limited | Antiretroviral composition |
GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
WO2014145195A1 (en) * | 2013-03-15 | 2014-09-18 | Cerovene, Inc. | Pharmaceuticals comprising a ph-dependent component and ph-raising agent |
GB201319792D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
CN105916598B (zh) | 2014-01-21 | 2020-07-17 | Bpsi控股有限责任公司 | 含有中链甘油酯的即释型膜包衣及用其包被的基质 |
US20150238514A1 (en) * | 2014-02-21 | 2015-08-27 | William Armstrong | Protective Supplement Configuration |
JP6642438B2 (ja) * | 2014-09-03 | 2020-02-05 | ライオン株式会社 | コーティング製剤及びその製造方法 |
EA036036B1 (ru) | 2014-11-07 | 2020-09-16 | Сигмойд Фарма Лимитед | Композиции, содержащие циклоспорин |
WO2017027778A1 (en) | 2015-08-13 | 2017-02-16 | Temple University-Of The Commonwealth System Of Higher Education | Calcium alginate dosage formulations, and methods of making and using thereof |
WO2017068600A1 (en) | 2015-10-22 | 2017-04-27 | Benny Antony | A process to enhance the bioactivity of ashwagandha extracts |
US20170119680A1 (en) | 2015-10-30 | 2017-05-04 | R.P. Scherer Technologies, Llc | Extended release film-coated capsules |
GB201607548D0 (en) * | 2016-04-29 | 2016-06-15 | Univ Central Lancashire | Solid dosage form |
WO2020161653A2 (en) * | 2019-02-07 | 2020-08-13 | Benny Antony | Mustard extract enriched with sinigrin having increased bioactivity and bioavailability of allyl isothiocyanate |
CN118369088A (zh) * | 2021-12-17 | 2024-07-19 | 帝斯曼知识产权资产管理有限公司 | 新的包衣系统(i) |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4123403A (en) | 1977-06-27 | 1978-10-31 | The Dow Chemical Company | Continuous process for preparing aqueous polymer microsuspensions |
US4330338A (en) | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
US4308251A (en) | 1980-01-11 | 1981-12-29 | Boots Pharmaceuticals, Inc. | Controlled release formulations of orally-active medicaments |
US4525345A (en) * | 1981-12-24 | 1985-06-25 | Verex Laboratories, Inc. | Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions |
US4502888A (en) | 1982-12-13 | 1985-03-05 | The Dow Chemical Company | Aqueous dispersions of plasticized polymer particles |
JPS59193831A (ja) * | 1983-04-18 | 1984-11-02 | Sankyo Co Ltd | 腸溶性製剤の製造法 |
US4668517A (en) * | 1985-04-04 | 1987-05-26 | Norwich Eaton Pharmaceuticals, Inc. | Furazolidone dosage form |
US4753801A (en) * | 1985-10-25 | 1988-06-28 | Eli Lilly And Company | Sustained release tablets |
US6468561B1 (en) * | 1986-06-19 | 2002-10-22 | Bpsi Holdings, Inc. | Aqueous film coating with improved properties |
US5840293A (en) * | 1988-11-16 | 1998-11-24 | Advanced Polymer Systems, Inc. | Ionic beads for controlled release and adsorption |
US5284659A (en) * | 1990-03-30 | 1994-02-08 | Cherukuri Subraman R | Encapsulated flavor with bioadhesive character in pressed mints and confections |
EP0520119A1 (de) * | 1991-06-17 | 1992-12-30 | Spirig Ag Pharmazeutische Präparate | Neue orale Diclofenaczubereitung |
JPH0672861A (ja) * | 1992-07-09 | 1994-03-15 | Takeda Chem Ind Ltd | 着色固形製剤 |
ES2137862B1 (es) * | 1997-07-31 | 2000-09-16 | Intexim S A | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. |
KR100387245B1 (ko) | 1997-10-17 | 2003-08-19 | 일양약품주식회사 | 유산균의안정화를위한미세장용성코팅과립 |
US6251430B1 (en) * | 1998-02-04 | 2001-06-26 | Guohua Zhang | Water insoluble polymer based sustained release formulation |
KR19990072826A (ko) * | 1998-02-26 | 1999-09-27 | 우재영 | 판크레아틴장용코팅과립의제조방법 |
US6372254B1 (en) | 1998-04-02 | 2002-04-16 | Impax Pharmaceuticals Inc. | Press coated, pulsatile drug delivery system suitable for oral administration |
DE19901686A1 (de) * | 1999-01-18 | 2000-07-20 | Gruenenthal Gmbh | Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung |
JP2001122788A (ja) * | 1999-10-22 | 2001-05-08 | Kokandou Seiyaku Kk | 医薬用固形組成物 |
US6420473B1 (en) | 2000-02-10 | 2002-07-16 | Bpsi Holdings, Inc. | Acrylic enteric coating compositions |
US20020132001A1 (en) * | 2000-05-11 | 2002-09-19 | Garthwaite Susan M. | Aldosterone antagonist composition for release during aldosterone acrophase |
CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
US20030031772A1 (en) * | 2001-03-28 | 2003-02-13 | Zehner Lee R. | Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glyemic index |
US6759058B1 (en) | 2001-04-25 | 2004-07-06 | Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences | Enteric-coated proliposomal formulations for poorly water soluble drugs |
KR100979877B1 (ko) * | 2001-09-28 | 2010-09-02 | 뉴트라슈틱스 인코포레이티드 | 생물학적 성분의 전달 시스템 |
US20030133982A1 (en) | 2001-12-20 | 2003-07-17 | Heimlich John M. | Zero-order sustained release dosage forms and method of making same |
CN1176653C (zh) * | 2002-08-26 | 2004-11-24 | 鲁南制药股份有限公司 | 阿尼西坦缓释胶囊 |
US6703044B1 (en) | 2002-10-25 | 2004-03-09 | Dexcel Pharma Tech, Ltd | Venlafaxine formulations |
KR100570419B1 (ko) * | 2004-01-14 | 2006-04-11 | 코오롱제약주식회사 | 염산 탐술로신의 경구 투여용 서방성 펠렛 조성물 및 그제조방법 |
-
2005
- 2005-03-24 AU AU2005231145A patent/AU2005231145B8/en active Active
- 2005-03-24 BR BRPI0508075-4A patent/BRPI0508075A/pt not_active IP Right Cessation
- 2005-03-24 KR KR1020067022599A patent/KR20070007868A/ko not_active Application Discontinuation
- 2005-03-24 CA CA2555114A patent/CA2555114C/en active Active
- 2005-03-24 WO PCT/US2005/009713 patent/WO2005097082A1/en active Application Filing
- 2005-03-24 JP JP2007506255A patent/JP2007530683A/ja active Pending
- 2005-03-24 US US11/088,352 patent/US7709025B2/en active Active
- 2005-03-24 MX MXPA06010488A patent/MXPA06010488A/es active IP Right Grant
- 2005-03-24 EP EP05729278A patent/EP1729742A1/en not_active Withdrawn
- 2005-03-24 CN CN2005800101815A patent/CN1938006B/zh not_active Expired - Fee Related
-
2006
- 2006-08-02 IL IL177225A patent/IL177225A0/en unknown
- 2006-08-14 ZA ZA200606744A patent/ZA200606744B/xx unknown
- 2006-10-31 NO NO20064983A patent/NO20064983L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL177225A0 (en) | 2006-12-10 |
WO2005097082A1 (en) | 2005-10-20 |
EP1729742A1 (en) | 2006-12-13 |
US7709025B2 (en) | 2010-05-04 |
BRPI0508075A (pt) | 2007-07-17 |
US20050220878A1 (en) | 2005-10-06 |
JP2007530683A (ja) | 2007-11-01 |
AU2005231145B8 (en) | 2010-11-11 |
CN1938006A (zh) | 2007-03-28 |
AU2005231145B2 (en) | 2010-10-28 |
AU2005231145A1 (en) | 2005-10-20 |
CA2555114C (en) | 2012-05-29 |
MXPA06010488A (es) | 2006-12-19 |
CN1938006B (zh) | 2010-11-10 |
ZA200606744B (en) | 2008-02-27 |
CA2555114A1 (en) | 2005-10-20 |
KR20070007868A (ko) | 2007-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20064983L (no) | Enterisk opploselig belegg til oralt inntakbare substrater | |
WO2005101983A3 (en) | Gastric retention system | |
NO20090346L (no) | Pyrazolderivater som inhibitorer av cytokrom P450 | |
WO2008049116A3 (en) | Substituted indoles | |
NO20081878L (no) | Diacylindazolderivater som lipase- og fosfolipaseinhibitorer | |
NO20052524L (no) | Aminerte isofiavonoidderivater og anvendelse derav | |
AU2003297581A1 (en) | Methods, systems and compositions for fire retarding substrates | |
WO2006063070A3 (en) | All surface data for use in substrate inspection | |
NO20090295L (no) | Substituerte heteroarylderivater | |
WO2005123277A3 (en) | Optical films and methods of making the same | |
NO20065190L (no) | Farmasoytiske sammensetninger omfattende en amfifil stivelse | |
EP2308867A3 (en) | 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses | |
WO2007089881A3 (en) | Electrospray coating of objects | |
DK1940703T3 (da) | Anordning til emballering og udlevering af faste formede legemer, specielet til orale tabletter og/eller kapsler | |
WO2005101112A3 (en) | Optical films and methods of making the same | |
BRPI0719395C1 (pt) | tablete revestido de filme | |
EP1260219A3 (en) | Dip coating compositions containing cellulose ethers | |
NO20081160L (no) | Benzimidazoltiofen forbindelser | |
WO2008129517A3 (en) | A stabilized delayed release pharmaceutical composition of rabeprazole | |
WO2007065595A3 (en) | Xanthine derivatives, processes for preparing them and their uses | |
NO20064934L (no) | Fremgangsmate for fremstilling av et fast, farmasoytisk preparat | |
EP1297827A3 (en) | Film forming composition comprising sucralose and carrageenan | |
TW200636521A (en) | All surface data for use in substrate inspection | |
WO2006044077A3 (en) | Controlled release composition with semi-permeable membrane and poloxamer flux enhancer | |
DK1181047T4 (da) | Sammensætning indeholdende alkalisk sphingomyelase af bakteriel oprindelse til brug som diætært middel, kosttilskud eller farmaceutisk produkt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |